{"id":"W2950646286","doi":"10.1097/01.hs9.0000564672.91201.a6","title":"S1606 SAFETY AND EFFICACY OF COMBINATION OF SELINEXOR, DARATUMUMAB, AND DEXAMETHASONE (SDD) IN PATIENTS WITH MULTIPLE MYELOMA (MM) PREVIOUSLY EXPOSED TO PROTEASOME INHIBITORS AND IMMUNOMODULATORY DRUGS","year":2019,"lang":"en","type":"article","venue":"HemaSphere","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hôpital Maisonneuve-Rosemont; Vancouver General Hospital; CancerCare Manitoba; Royal Victoria Hospital; Dalhousie University; Princess Margaret Cancer Centre","funders":"","keywords":"Daratumumab; Tolerability; Medicine; Refractory (planetary science); Internal medicine; Oncology; Dexamethasone; Proteasome inhibitor; Phases of clinical research; Carfilzomib; Multiple myeloma; Pharmacology; Lenalidomide; Gastroenterology; Toxicity; Adverse effect; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000844226,0.0004678187,0.001304886,0.0003245219,0.000227909,0.0006232341,0.0003179917,0.0007226591,0.002193957],"category_scores_gemma":[0.0007399889,0.0002381238,0.0008724449,0.000284343,0.0003465493,0.0005263168,0.0002440347,0.001491645,0.0006772784],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000565578,"about_ca_system_score_gemma":0.0005819305,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002475364,"about_ca_topic_score_gemma":0.000609741,"domain_scores_codex":[0.9997165,0.0001177119,0.00003012481,0.00004716303,0.00005059961,0.00003782933],"domain_scores_gemma":[0.9994038,0.0001185199,0.0001755484,0.00003721238,0.00004431668,0.0002205731],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5746802,0.02597627,0.05715663,0.001089497,0.002141635,0.0009654007,0.0004120437,0.00390631,0.08823042,0.0002700412,0.003523239,0.2416483],"study_design_scores_gemma":[0.1149154,0.7481857,0.1060536,0.0001217823,0.001253863,0.002255918,0.0001353157,0.004148041,0.01368335,0.0002344465,0.008951591,0.00006100912],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9963099,0.001927088,0.000133118,0.0001598581,0.00004674364,0.000148486,0.0002950192,0.00002376158,0.0009558869],"genre_scores_gemma":[0.9975867,0.0005638302,0.0002623803,0.0002154392,0.00008301916,0.0001010621,0.0005051876,0.000006237901,0.0006761393],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002193957,"threshold_uncertainty_score":0.007339537,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.006718724720766075,"score_gpt":0.2381503459862727,"score_spread":0.2314316212655067,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}